PL360597A1 - Trwałe w czasie przechowywania roztwory cyprofloksacyny do infuzji, o zmniejszonej zawartości kwasu - Google Patents

Trwałe w czasie przechowywania roztwory cyprofloksacyny do infuzji, o zmniejszonej zawartości kwasu

Info

Publication number
PL360597A1
PL360597A1 PL01360597A PL36059701A PL360597A1 PL 360597 A1 PL360597 A1 PL 360597A1 PL 01360597 A PL01360597 A PL 01360597A PL 36059701 A PL36059701 A PL 36059701A PL 360597 A1 PL360597 A1 PL 360597A1
Authority
PL
Poland
Prior art keywords
ciprofloxacin
infusion
stable
storage
acid content
Prior art date
Application number
PL01360597A
Other languages
English (en)
Inventor
Klaus Sommermeyer
Hans-Jörg Müller
Tilo Hniopek
Bernd Eschenbach
Original Assignee
Fresenius Kabi Deutchland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutchland Gmbh filed Critical Fresenius Kabi Deutchland Gmbh
Publication of PL360597A1 publication Critical patent/PL360597A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL01360597A 2000-09-29 2001-09-27 Trwałe w czasie przechowywania roztwory cyprofloksacyny do infuzji, o zmniejszonej zawartości kwasu PL360597A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10048510A DE10048510A1 (de) 2000-09-29 2000-09-29 Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt

Publications (1)

Publication Number Publication Date
PL360597A1 true PL360597A1 (pl) 2004-09-20

Family

ID=7658237

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01360597A PL360597A1 (pl) 2000-09-29 2001-09-27 Trwałe w czasie przechowywania roztwory cyprofloksacyny do infuzji, o zmniejszonej zawartości kwasu

Country Status (17)

Country Link
US (1) US20040082593A1 (pl)
EP (1) EP1320368A1 (pl)
JP (1) JP2004509921A (pl)
KR (1) KR20030068541A (pl)
CN (1) CN1466457A (pl)
AU (1) AU2002214993A1 (pl)
BR (1) BR0114293A (pl)
CA (1) CA2420556A1 (pl)
DE (1) DE10048510A1 (pl)
HU (1) HUP0302256A2 (pl)
IL (1) IL154509A0 (pl)
MX (1) MXPA03002770A (pl)
NO (1) NO20031411D0 (pl)
PL (1) PL360597A1 (pl)
SK (1) SK3322003A3 (pl)
WO (1) WO2002026233A1 (pl)
ZA (1) ZA200301459B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2591000B1 (en) 2010-07-09 2017-05-17 Janssen Vaccines & Prevention B.V. Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
ES2768651T3 (es) 2013-04-25 2020-06-23 Kyorin Seiyaku Kk Composición farmacéutica sólida
CN105338981B (zh) 2013-04-25 2017-10-13 杏林制药株式会社 固体药用组合物
JP6018334B2 (ja) 2014-10-23 2016-11-02 杏林製薬株式会社 固形医薬組成物
JP6031217B1 (ja) 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
EP3305294A4 (en) 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE
WO2016195020A1 (ja) 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
CN114767627B (zh) * 2022-05-17 2024-05-31 广州南鑫药业有限公司 一种乳酸环丙沙星氯化钠注射液的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
WO1990001933A1 (en) * 1988-08-26 1990-03-08 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
DE10018781A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Infusionslösungen des Ciprofloxacins mit verbesserter Lagerfähigkeit
DE10018783A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt

Also Published As

Publication number Publication date
HUP0302256A2 (hu) 2003-11-28
BR0114293A (pt) 2003-07-29
NO20031411D0 (no) 2003-03-27
DE10048510A1 (de) 2002-05-16
AU2002214993A1 (en) 2002-04-08
US20040082593A1 (en) 2004-04-29
CN1466457A (zh) 2004-01-07
ZA200301459B (en) 2003-08-27
WO2002026233A1 (de) 2002-04-04
MXPA03002770A (es) 2004-12-13
SK3322003A3 (en) 2003-07-01
WO2002026233B1 (de) 2002-07-04
KR20030068541A (ko) 2003-08-21
CA2420556A1 (en) 2003-02-25
EP1320368A1 (de) 2003-06-25
JP2004509921A (ja) 2004-04-02
IL154509A0 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
GB0005839D0 (en) Storage and delivery of micro-organisms
WO2002002093A3 (en) Combination containing an antifolate and methylmalonic acid lowering agent
PT1214056E (pt) Formulacoes em suspensao topica que contem ciprofloxacina e dexametasona
IL149662A (en) Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
SI1267880T1 (sl) Formulacija z nizko dozo entekavirja in uporaba
IL149758A0 (en) Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
AU4303600A (en) Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
AU2002254942A1 (en) Paracetamol solutions which are stable in storage and ready for infusion
AU2961602A (en) Improvements in and relating to the distribution of content
AU2002229616A1 (en) Improvements in and relating to the distribution of content
ZA200301459B (en) Infusion of ciprofloxacin having reduced acid content and being stable in storage.
AU2001273941A1 (en) Ciprofloxacin infusion solutions having a good storage stability
WO2002032397A8 (en) Electroprocessing in drug delivery and cell encapsulation
PL362965A1 (pl) Zastosowanie profilaktyczne i terapeutyczne oltiprazu jako środka przeciwko zwłóknieniu i marskościwątroby oraz kompozycja farmaceutyczna zawierająca oltipraz
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
AR027904A1 (es) Composicion de implante con contenido de acetato de melengestrol y acetato de trenbolona
GB9927810D0 (en) Hydrate storage and transportation
AU2002347455A1 (en) Improvements in and relating to content delivery
GB0022260D0 (en) Improvements in and relating to bunding for storage of fluid materials
GB0028850D0 (en) Container storage and secure unattended delivery of goods
AU2001260198A1 (en) Ciprofloxacin infusion solutions with improved storage life
GB2356341B (en) Improvements in and relating to furniture
GB2371596B (en) Improvements in and relating to lockable storage containers
GB2381934B (en) Improvements in and relating to devices for storage
GB0024016D0 (en) Storage and delivery means